An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents

BACKGROUND: The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). Due to the toxicity of this treatment, alternative therapies are often offered to patients. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Péron, Julien, Polivka, Valentine, Chabaud, Sylvie, Poupart, Marc, Ceruse, Philippe, Ramade, Antoine, Girodet, Didier, Zrounba, Philippe, Fayette, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096421/
https://www.ncbi.nlm.nih.gov/pubmed/25011678
http://dx.doi.org/10.1186/1471-2407-14-504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096421/
https://www.ncbi.nlm.nih.gov/pubmed/25011678
http://dx.doi.org/10.1186/1471-2407-14-504

Ejemplares similares